Data Reporting, Compliance and Integrity – News and Features

This article will explore the problem of nosocomial infections, what causes them and what can be done to treat and prevent them.

In this article, we’ll review how advanced eQMS adoption can improve product quality, enable sustainable compliance, foster continuous improvement and create a culture of quality that will make a positive impact for every stakeholder involved in the pharmaceutical product lifecycle.

捷克葡萄牙直播interviewed Frank DeRosa, chief technology officer and head of research at the mRNA Center of Excellence, Sanofi, to discuss the “bright future” of mRNA platforms.

To realize the potential of Lab 4.0, organizations will need to improve their digital maturity. The critical first step is connecting people, equipment, consumables, systems and data. Here, we explore the benefits of this connectivity, and ways to develop a laboratory fit for the future.

With the world’s population predicted to increase to 10 billion people by 2050, there is a pressing need to find more sustainable and healthy supplies of food. In this article, we highlight the latest research on developing foods for the future.

Genomic health data brings unique challenges when it comes to storage, management, analysis and collaboration. This article explores how TREs can help to bridge the gap for health data so that the information can be scaled and secured.

In this insight, Dr. Zachary Pitluk, vice president of life sciences and healthcare at Paradigm4, gives his view on the major developments that 2022 will hold for informatics in biopharma.

In this article, we will explore some of the recent advances in proteomics and their potential wider impact.

In this article we introduce you to the lab of the future, what you should expect to find in it and what impacts it will have on scientific research and industry.

This article outlines some of the drawbacks associated with current models used in drug toxicity studies and highlights how organ-chips could enable a move towards safer, efficient and more humane drug development.